Publisher: Elsevier

Related content
Volume 12, Number 17, 2 September 2002

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Contents List
pp. ii-ii(1)

Favourites:Add to Favourites
Favourites:Add to Favourites

Graphical Abstracts
pp. 2249-2262(14)

Favourites:Add to Favourites

Design, synthesis and biological activity of carbohydrate-Containing peptidomimetics as new ligands for the human tachykinin NK-2 receptor
pp. 2263-2266(4)
Authors: Capozzi, G.; Giannini, S.; Menichetti, S.; Nativi, C.; Giolitti, A.; Patacchini, R.; Perrotta, E.; Altamura, M.; Alberto Maggi, C.

Favourites:Add to Favourites

l-Cysteine based N-type calcium channel blockers: structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models
pp. 2267-2269(3)
Authors: Seko, T.; Kato, M.; Kohno, H.; Ono, S.; Hashimura, K.; Takenobu, Y.; Takimizu, H.; Nakai, K.; Maegawa, H.; Katsube, N.; Toda, M.

Favourites:Add to Favourites

3D-QSAR studies on 4-hydroxyphenylpyruvate dioxygenase inhibitors by comparative molecular field analysis (CoMFA)
pp. 2271-2275(5)
Authors: Huang, M.; Yang, D.; Shang, Z.; Zou, J.; Yu, Q.

Favourites:Add to Favourites

In vivo active antimalarial isonitriles
pp. 2277-2279(3)
Authors: Singh, C.; Srivastav, N.C.; Puri, S.K.

Favourites:Add to Favourites
Favourites:Add to Favourites

3-Pyrroline containing arylacetamides - A novel series of remarkably selective -agonists
pp. 2287-2290(4)
Authors: Mou, Q.; Chen, J.; Zhu, Y.; Zhou, D.; Chi, Z.; Long Y.-Q.

Favourites:Add to Favourites

Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines
pp. 2291-2294(4)
Authors: Kawanaka, Y.; Kobayashi, K.; Kusuda, S.; Tatsumi, T.; Murota, M.; Nishiyama, T.; Hisaichi, K.; Fujii, A.; Hirai, K.; Naka, M.; Komeno, M.; Nakai, H.; Toda, M.

Favourites:Add to Favourites

Preparation of chiral 4-benzyloxymethyldihydrofuran-2-one using lipase-catalyzed kinetic resolution: synthesis of (-)-Virginiae Butanolide C (VB C)
pp. 2295-2297(3)
Authors: Takabe, K.; Mase, N.; Matsumura, H.; Hasegawa, T.; Iida, Y.; Kuribayashi, H.; Adachi, K.; Yoda, H.; Ao, M.

Favourites:Add to Favourites

Antimalarial activity of ferrocenyl chalcones
pp. 2299-2302(4)
Authors: Wu, X.; Wilairat, P.; Go M.-L.

Favourites:Add to Favourites

Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship
pp. 2303-2307(5)
Authors: Sharma, V.M.; Prasanna, P.; Adi Seshu, K.V.; Renuka, B.; Laxman Rao, C.V.; Sunil Kumar, G.; Narasimhulu, C.P.; Aravind Babu, P.; Puranik, R.C.; Subramanyam, D.; Venkateswarlu, A.; Rajagopal, S.; Kumar, K.B.S.; Rao, C.S.; Mamidi, N.V.S.R.; Deevi, D.S.; Ajaykumar, R.; Rajagopalan, R.

Favourites:Add to Favourites
Favourites:Add to Favourites

A Prenylated Flavonol, Sophoflavescenol: A Potent and Selective Inhibitor of cGMP Phosphodiesterase 5
pp. 2313-2316(4)
Authors: Shin, H.J.; Kim, H.J.; Kwak, J.H.; Chun, H.O.; Kim, J.H.; Park, H.; Kim, D.H.; Lee, Y.S.

Favourites:Add to Favourites
Favourites:Add to Favourites

First Example of an Antibody-Catalyzed Aza Diels-Alder Reaction
pp. 2321-2324(4)
Authors: Shi, Z.; Yang, B.; Wu Y.-L.; Pan, Y.; Ji, Y.; Yeh, M.

Favourites:Add to Favourites

Oxidative DNA base damage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine)
pp. 2325-2329(5)
Authors: Kotandeniya, D.; Ganley, B.; Gates, K.S.

Favourites:Add to Favourites

Synthesis and Thrombolytic Activity of Pseudopeptides Related to Fibrinogen Fragment
pp. 2331-2333(3)
Authors: Wu, Y.; Zhao, M.; Wang, C.; Peng, S.

Favourites:Add to Favourites
Favourites:Add to Favourites

Muraymycins, novel peptidoglycan biosynthesis inhibitors: semisynthesis and SAR of Their derivatives
pp. 2341-2344(4)
Authors: Lin, Y.I.; Li, Z.; Francisco, G.D.; McDonald, L.A.; Davis, R.A.; Singh, G.; Yang, Y.; Mansour, T.S.

Favourites:Add to Favourites

Preliminary Structure-Antiangiogenic Activity Relationships of 4-Senecioyloxymethyl-6,7-dimethoxycoumarin
pp. 2345-2348(4)
Authors: Nam, N.; Kim, Y.; You, Y.; Hong, D.; Kim, H.; Ahn B.-Z.

Favourites:Add to Favourites

Clarification of Mechanism of Human Sputum Elastase Inhibition by a New Inhibitor, ONO-5046, Using Electrospray Ionization Mass Spectrometry
pp. 2349-2353(5)
Authors: Nakayama, Y.; Odagaki, Y.; Fujita, S.; Matsuoka, S.; Hamanaka, N.; Nakai, H.; Toda, M.

Favourites:Add to Favourites

Preparation of oxime dual NK1/NK2 antagonists with reduced NK3 affinity
pp. 2355-2358(4)
Authors: Reichard, G.A.; Grice, C.A.; Shih, N.; Spitler, J.; Majmundar, S.; Wang, S.D.; Paliwal, S.; Anthes, J.C.; Piwinski, J.J.

Favourites:Add to Favourites

Design and synthesis of conformationally restricted eight-Membered ring diketones as potential serine protease inhibitors
pp. 2359-2362(4)
Authors: Pearson, N.D.; Eggleston, D.S.; Haltiwanger, R.C.; Hibbs, M.; Laver, A.J.; Kaura, A.C.

Favourites:Add to Favourites

Synthesis of ODNs Containing 4-Methylamino-1,8-naphthalimide as a fluorescence probe in DNA
pp. 2363-2366(4)
Authors: Kawai, K.; Kawabata, K.; Tojo, S.; Majima, T.

Favourites:Add to Favourites

Novel Inhibitors of Plasminogen Activator Inhibitor-1: Development of New Templates From Diketopiperazines
pp. 2367-2370(4)
Authors: Wang, S.; Golec, J.; Miller, W.; Milutinovic, S.; Folkes, A.; Williams, S.; Brooks, T.; Hardman, K.; Charlton, P.; Wren, S.; Spencer, J.

Favourites:Add to Favourites

Novel 20-Carbonate Linked Prodrugs of Camptothecin and 9-Aminocamptothecin Designed for Activation by Tumour-Associated Plasmin
pp. 2371-2376(6)
Authors: de Groot, F.M.H.; Busscher, G.F.; Aben, R.W.M.; Scheeren, H.W.

Favourites:Add to Favourites

Potential Anxiolytic Agents. Part 4: Novel Orally-Active N5-Substituted Pyrido[1,2-a]benzimidazoles with High GABA-A Receptor Affinity
pp. 2381-2386(6)
Authors: Jordan, A.D.; Vaidya, A.H.; Rosenthal, D.I.; Dubinsky, B.; Kordik, C.P.; Sanfilippo, P.J.; Wu, W.; Reitz, A.B.

Favourites:Add to Favourites

Synthesis and dopamine transporter binding affinities of 3α-Benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes
pp. 2387-2390(4)
Authors: Bradley, A.L.; Izenwasser, S.; Wade, D.; Klein-Stevens, C.; Zhu, N.; Trudell, M.L.

Favourites:Add to Favourites

Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid
pp. 2391-2394(4)
Authors: Ahmed, S.; James, K.; Owen, C.P.

Favourites:Add to Favourites

Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
pp. 2395-2398(4)
Authors: Bhattacharya, G.; Salem, M.M.; Werbovetz, K.A.

Favourites:Add to Favourites

C-3 Amido-Indole cannabinoid receptor modulators
pp. 2399-2402(4)
Authors: Hynes, J.; Leftheris, K.; Wu, H.; Pandit, C.; Chen, P.; Norris, D.J.; Chen, B.; Zhao, R.; Kiener, P.A.; Chen, X.; Turk, L.A.; Patil-Koota, V.; Gillooly, K.M.; Shuster, D.J.; McIntyre, K.W.

Favourites:Add to Favourites
Favourites:Add to Favourites

Structure-Activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH2 at the human melanocortin-1 and -4 receptors: arginine substitution
pp. 2407-2410(4)
Authors: Cheung A.W.-H.; Danho, W.; Swistok, J.; Qi, L.; Kurylko, G.; Franco, L.; Yagaloff, K.; Chen, L.

Favourites:Add to Favourites

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists
pp. 2415-2418(4)
Authors: Kopka, I.E.; Lin, L.S.; Mumford, R.A.; Lanza, T.; Magriotis, P.A.; Young, D.; DeLaszlo, S.E.; MacCoss, M.; Mills, S.G.; van Riper, G.; McCauley, E.; Lyons, K.; Vincent, S.; Egger, L.A.; Kidambi, U.; Stearns, R.; Colletti, A.; Teffera, Y.; Tong, S.; Owens, K.; Levorse, D.; Schmidt, J.A.; Hagmann, W.K.

Favourites:Add to Favourites

Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains
pp. 2419-2422(4)
Authors: Cheng, Y.; Zhang, F.; Rano, T.A.; Lu, Z.; Schleif, W.A.; Gabryelski, L.; Olsen, D.B.; Stahlhut, M.; Rutkowski, C.A.; Lin, J.H.; Jin, L.; Emini, E.A.; Chapman, K.T.; Tata, J.R.

Favourites:Add to Favourites

Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains
pp. 2423-2426(4)
Authors: Duffy, J.L.; Kevin, N.J.; Kirk, B.A.; Chapman, K.T.; Schleif, W.A.; Olsen, D.B.; Stahlhut, M.; Rutkowski, C.A.; Kuo, L.C.; Jin, L.; Lin, J.H.; Emini, E.A.; Tata, J.R.

Favourites:Add to Favourites

Quinoline-3-carbothioamides and related compounds as novel immunomodulating agents
pp. 2427-2430(4)
Authors: Tojo, T.; Spears, G.W.; Tsuji, K.; Nishimura, H.; Ogino, T.; Seki, N.; Sugiyama, A.; Matsuo, M.

Favourites:Add to Favourites

Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent gram-positive and gram-negative antibacterial agents
pp. 2431-2434(4)
Authors: Cheng, H.; Dirlam, J.P.; Ziegler, C.B.; Lundy, K.M.; Hayashi, S.F.; Kamicker, B.J.; Dutra, J.K.; Daniel, K.L.; Santoro, S.L.; George, D.M.; Bertsche, C.D.; Sakya, S.M.; Suarez-Contreras, M.

Favourites:Add to Favourites

Thiourea-based gemfibrozil analogues as HDL-elevating agents
pp. 2439-2442(4)
Authors: Coppola, G.M.; Damon, R.E.; Eskesen, J.B.; France, D.S.; Paterniti, J.R.

Favourites:Add to Favourites

Arylpiperazine substituted heterocycles as Selective α1a adrenergic antagonists
pp. 2443-2446(4)
Authors: Khatuya, H.; Hutchings, R.H.; Kuo, G.; Pulito, V.L.; Jolliffe, L.K.; Li, X.; Murray, W.V.

Favourites:Add to Favourites

An improved synthesis of the C-linked glucuronide of N-(4-Hydroxyphenyl)retinamide
pp. 2447-2450(4)
Authors: Walker, J.R.; Alshafie, G.; Abou-Issa, H.; Curley, R.W.

Favourites:Add to Favourites

1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT7 receptor ligands
pp. 2451-2454(4)
Authors: Isaac, M.B.; Xin, T.; O'Brien, A.; St-Martin, D.; Naismith, A.; MacLean, N.; Wilson, J.; Demchyshyn, L.; Tehim, A.; Slassi, A.

Favourites:Add to Favourites

Synthesis of cholesterol-carborane conjugate for targeted drug delivery
pp. 2455-2458(4)
Authors: Ji, B.; Peacock, G.; Lu, D.R.

Favourites:Add to Favourites

A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer
pp. 2459-2461(3)
Authors: Mhaka, A.; Denmeade, S.R.; Yao, W.; Isaacs, J.T.; Khan, S.R.

Favourites:Add to Favourites

Non-Peptide αv3 Antagonists. Part 4: Potent and Orally Bioavailable Chain-Shortened RGD Mimetics
pp. 2463-2465(3)
Authors: Coleman, P.J.; Askew, B.C.; Hutchinson, J.H.; Whitman, D.B.; Perkins, J.J.; Hartman, G.D.; Rodan, G.A.; Leu, C.; Prueksaritanont, T.; Fernandez-Metzler, C.; Merkle, K.M.; Lynch, R.; Lynch, J.J.; Rodan, S.B.; Duggan, M.E.

Favourites:Add to Favourites

Tryptophanyl phosphoramidates as prodrugs of synadenol and its E-isomer: synthesis and biological activity
pp. 2467-2470(4)
Authors: Wang, R.; Corbett, T.H.; Cheng, Y.; Drach, J.C.; Kern, E.R.; Mitsuya, H.; Zemlicka, J.

Favourites:Add to Favourites

Investigation of the PDZ domain ligand binding site using chemically modified peptides
pp. 2471-2474(4)
Authors: Novak, K.A.P.; Fujii, N.; Guy, R.K.

Favourites:Add to Favourites

N-Cycloalkanoyl-l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists
pp. 2475-2478(4)
Authors: Sidduri, A.; Tilley, J.W.; Hull, K.; Ping Lou, J.; Kaplan, G.; Sheffron, A.; Chen, L.; Campbell, R.; Guthrie, R.; Huang, T.; Huby, N.; Rowan, K.; Schwinge, V.; Renzetti, L.M.

Favourites:Add to Favourites

N-Aroyl-l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists
pp. 2479-2482(4)
Authors: Sidduri, A.; Tilley, J.W.; Lou, J.P.; Chen, L.; Kaplan, G.; Mennona, F.; Campbell, R.; Guthrie, R.; Huang, T.; Rowan, K.; Schwinge, V.; Renzetti, L.M.

Favourites:Add to Favourites

Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR-) Rats
pp. 2483-2486(4)
Authors: McDonagh, A.F.; Lightner, D.A.; Boiadjiev, S.E.; Brower, J.O.; Norona, W.S.

Favourites:Add to Favourites

Bromotyrosine-Derived Natural and Synthetic Products as Inhibitors of Mycothiol-S-Conjugate Amidase
pp. 2487-2490(4)
Authors: Nicholas, G.M.; Eckman, L.L.; Ray, S.; Hughes, R.O.; Pfefferkorn, J.A.; Barluenga, S.; Nicolaou, K.C.; Bewley, C.A.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more